Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q2

2796.TEDINET S100PYDZ
Period2022-06-01 → 2022-11-30
Filed2023-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥25.7bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥25.9bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income¥573m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥788m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income¥566m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥814m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥394m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥775m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)¥72m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥250m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income¥77m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥254m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥23.3bnat 2022-11-30Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.2bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥16.6bnat 2022-11-30Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.7bnat 2022-11-30Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.5bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥4.3bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥4.3bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥3.3bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow¥1.6bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥713m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥17m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥448m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥292m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥337m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥792m2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.0bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.0bn2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥7.762022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.082022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.942021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.092021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥5.932022-06-01 → 2022-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥20.342021-06-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio27.4%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.8%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2022-11-30¥375m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2022-11-30¥375m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2022-11-30¥26m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥153m
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2022-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2022-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2022-11-30−¥129m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2022-11-30¥328m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2022-11-30¥328m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2022-11-30¥38m
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2022-11-30¥20.9bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2022-11-30¥20.9bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2022-11-30¥744m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-11-30¥45m
—segment totalrevenue2022-06-01 → 2022-11-30¥25.4bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥25.4bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥699m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥25.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥25.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥726m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2021-11-30¥437m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2021-11-30¥437m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2021-11-30¥13m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥155m
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2021-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2021-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2021-11-30−¥101m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2021-11-30¥346m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2021-11-30¥346m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2021-11-30¥59m
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2021-11-30¥21.0bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2021-11-30¥21.0bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2021-11-30¥938m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-11-30¥32m
—segment totalrevenue2021-06-01 → 2021-11-30¥25.5bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥25.5bn
—segment totalsegment profit2021-06-01 → 2021-11-30¥929m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥25.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥25.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥943m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 552
ItemContextValueUnit
Commission fee noiPrior1YTDDuration8000000JPY
Commission fee noiCurrentYTDDuration14000000JPY
Rent income noiPrior1YTDDuration9000000JPY
Rent income noiCurrentYTDDuration8000000JPY
Other noiPrior1YTDDuration68000000JPY
Other noiCurrentYTDDuration11000000JPY
Non operating incomePrior1YTDDuration87000000JPY
Non operating incomeCurrentYTDDuration35000000JPY
Interest expenses noePrior1YTDDuration35000000JPY
Interest expenses noeCurrentYTDDuration28000000JPY
Rent cost noePrior1YTDDuration4000000JPY
Rent cost noeCurrentYTDDuration4000000JPY
Other noePrior1YTDDuration22000000JPY
Other noeCurrentYTDDuration9000000JPY
Non operating expensesPrior1YTDDuration61000000JPY
Non operating expensesCurrentYTDDuration42000000JPY
Ordinary incomePrior1YTDDuration814000000JPY
Ordinary incomeCurrentYTDDuration566000000JPY
Reversal of provision for loss on store closing eiPrior1YTDDuration21000000JPY
Reversal of provision for loss on store closing eiCurrentYTDDuration－JPY
Subsidy eiPrior1YTDDuration－JPY
Subsidy eiCurrentYTDDuration42000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration21000000JPY
Extraordinary incomeCurrentYTDDuration42000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration5000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration18000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration27000000JPY
Impairment loss elPrior1YTDDuration42000000JPY
Impairment loss elCurrentYTDDuration36000000JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration－JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration41000000JPY
Loss on cancellation of leasehold contracts elPrior1YTDDuration－JPY
Loss on cancellation of leasehold contracts elCurrentYTDDuration103000000JPY
Extraordinary lossPrior1YTDDuration60000000JPY
Extraordinary lossCurrentYTDDuration213000000JPY
Income before income taxesPrior1YTDDuration775000000JPY
Income before income taxesCurrentYTDDuration394000000JPY
Income taxesPrior1YTDDuration520000000JPY
Income taxesCurrentYTDDuration317000000JPY
Profit lossPrior1YTDDuration254000000JPY
Profit lossCurrentYTDDuration77000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration3000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration4000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration250000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration72000000JPY
Profit lossPrior1YTDDuration254000000JPY
Profit lossCurrentYTDDuration77000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass